# Taking GLP-1 Drugs Like Ozempic Increases Heat-Related Health Risks
People taking GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro face elevated risks during hot weather. These medications affect how the body regulates temperature and manages fluids, creating dangerous conditions when temperatures climb.
GLP-1 drugs work by slowing gastric emptying and reducing appetite. This mechanism also impairs sweating, the body's primary cooling system. Additionally, these medications increase urination, leading to dehydration. Together, these effects compromise thermoregulation during heat exposure.
Heat-related illnesses pose real threats for GLP-1 users. Dehydration can develop quickly, especially during exercise or outdoor activities in summer. Heat exhaustion and heat stroke become more likely, even at moderate temperatures. Users may not recognize warning signs like dizziness, nausea, or confusion because GLP-1 medications already cause gastrointestinal side effects.
Medical professionals recommend practical precautions. Stay hydrated by drinking water consistently throughout the day, not just when thirsty. Avoid intense outdoor exercise during peak heat hours (typically 10 a.m. to 4 p.m.). Wear lightweight, light-colored clothing and seek shade frequently. Monitor urine color as a hydration marker; pale yellow indicates adequate fluids.
Heat also affects medication storage. GLP-1 injectable medications require refrigeration between 36-46°F. Temperatures above this range degrade the drug's effectiveness. Users traveling or spending time outdoors should use cooling cases or insulated travel bags specifically designed for injectable medications.
Inform your healthcare provider about planned activities in hot climates. They may adjust dosing schedules or provide additional guidance based on your specific situation. Watch for signs of heat illness